Oncospace, Inc. — Form D/A
Oncospace, Inc. of BALTIMORE, MD, a company, filed a Form D amendment with the SEC on 2019-05-15. The offering totals $1.5M, of which $900K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-05-15
- Form: D/A
- Accession: 0001773640-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $900K
- Remaining: $600K
- Investors: 11
- Date of first sale: 2019-03-26
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-337126
Issuer
- Name: Oncospace, Inc.
- CIK: 0001773640
- Entity type: Corporation
- Jurisdiction: MARYLAND
- Incorporated: 2018
- Address: 1812 ASHLAND AVENUE SUITE 100, BALTIMORE, MD, 21205
- Phone: 608-239-6871
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Todd McNutt | Director | Baltimore, MD |
| Daniel Roche | Director | Baltimore, MD |
| Praveen Sinha | Director | Baltimore, MD |
| Todd McNutt | Executive Officer | Baltimore, MD |
| Praveen Sinha | Executive Officer | Baltimore, MD |
| Daniel Roche | Related Person | Baltimore, MD |
| Praveen Sinha | Related Person | Baltimore, MD |
| Todd McNutt | Related Person | Baltimore, MD |
Other filings by this issuer (1)
More